Related references
Note: Only part of the references are listed.GLORYx: Prediction of the Metabolites Resulting from Phase 1 and Phase 2 Biotransformations of Xenobiotics
Christina de Bruyn Kops et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2021)
Identification and structure characterization of five synthetic opioids: 3,4-methylenedioxy-U-47700,o-methyl-acetylfentanyl, 2-thiophenefentanyl, benzoylfentanyl and benzoylbenzylfentanyl
Magdalena Poplawska et al.
FORENSIC TOXICOLOGY (2021)
Comprehensive UHPLC-HR-MSE screening workflow optimized for use in routine laboratory medicine: Four workflows in one analytical method
Marie Mardal et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
Annagiulia Di Trana et al.
FRONTIERS IN PSYCHIATRY (2020)
How to perform spectrum-based LC-HR-MS screening for more than 1,000 NPS with HighResNPS consensus fragment ions
Anders Davidsen et al.
PLOS ONE (2020)
HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances
Marie Mardal et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2019)
Metabolic Pathways and Potencies of New Fentanyl Analogs
Maurice Wilde et al.
FRONTIERS IN PHARMACOLOGY (2019)
New Psychoactive Substances: A Matter of Time
Flaminia Pantano et al.
CURRENT NEUROPHARMACOLOGY (2019)
Correlations between metabolism and structural elements of the alicyclic fentanyl analogs cyclopropyl fentanyl, cyclobutyl fentanyl, cyclopentyl fentanyl, cyclohexyl fentanyl and 2,2,3,3-tetramethylcyclopropyl fentanyl studied by human hepatocytes and LC-QTOF-MS
Anna Astrand et al.
ARCHIVES OF TOXICOLOGY (2019)
Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects
Miriam Saiz-Rodriguez et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Detection of Fentanyl Analogs and Synthetic Opioids in Real Hair Samples
Alberto Salomone et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2019)
Metabolism of Fentanyl and Acetylfentanyl in Human-Induced Pluripotent Stem Cell-Derived Hepatocytes
Tatsuyuki Kanamori et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Metabolism of the new synthetic cannabinoid EG-018 in human hepatocytes by high-resolution mass spectrometry
Xingxing Diao et al.
FORENSIC TOXICOLOGY (2018)
Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection
Jeremy Carlier et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
New synthetic opioids in biological and non-biological matrices: A review of current analytical methods
Emilia Marchei et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2018)
Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids
Renata Solimini et al.
FRONTIERS IN PHARMACOLOGY (2018)
Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites
X. Diao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
In vitro metabolism of new synthetic cannabinoid SDB-006 in human hepatocytes by high-resolution mass spectrometry
Xingxing Diao et al.
FORENSIC TOXICOLOGY (2017)
Misuse of Novel Synthetic Opioids: A Deadly New Trend
Matthew P. Prekupec et al.
JOURNAL OF ADDICTION MEDICINE (2017)
Human Hepatocyte Metabolism of Novel Synthetic Cannabinoids MN-18 and Its 5-Fluoro Analog 5F-MN-18
Xingxing Diao et al.
CLINICAL CHEMISTRY (2017)
In Vitro and In Vivo Metabolite Identification Studies for the New Synthetic Opioids Acetylfentanyl, Acrylfentanyl, Furanylfentanyl, and 4-Fluoro-Isobutyrylfentanyl
Shimpei Watanabe et al.
AAPS JOURNAL (2017)
In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid
Jeremy Carlier et al.
CURRENT NEUROPHARMACOLOGY (2017)
Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry
Jeremy Cartier et al.
CLINICAL CHEMISTRY (2017)
Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes
Jeremy Carlier et al.
AAPS JOURNAL (2017)
Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry
Michael G. Feasel et al.
AAPS JOURNAL (2016)
Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry
Jeremy Carlier et al.
JOURNAL OF CHROMATOGRAPHY A (2016)
In vitro, in vivo and in silico metabolic profiling of -pyrrolidinopentiothiophenone, a novel thiophene stimulant
Madeleine J. Swortwood et al.
BIOANALYSIS (2016)
Interferences and contaminants encountered in modern mass spectrometry
Bernd O. Keller et al.
ANALYTICA CHIMICA ACTA (2008)
Share Paper
